RxDoctor Payments Data

Andrea Ferrara, MD

Colon & Rectal Surgery · Orlando, FLNPI 1407850779

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 34 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Medtronic at 34.2% of the total. Reporting peaked in 2022 at $888 and has fallen 81.3% since, to $166 in 2025. That places this record below the midpoint for colon & rectal surgery clinicians in FL, where the typical reported total is $4,865.

$3,155in general payments, 2019–2025

Across 34 payments — averaging $92.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1K
  • THD America, Inc.$436
  • Medical Device Business Services, Inc.$283
  • Intuitive Surgical$170
  • Axonics, Inc.$166
  • Stryker$165
  • plus $856 from 9 others
$27,507in research payments, 2019–2025

Across 8 payments — averaging $3438.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Ethicon Endo-surgery Inc.$28K

What the payments were for

  • Food & beverage$3,155100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,155 in reported general payments places this provider in the 40th percentile of 157 colon & rectal surgery providers in Florida.

See all colon & rectal surgery providers in Florida

Medicare billing

Part B allowed, 2024
$62,279
Medicare patients
111
Services billed
370

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide25$14,897
Hydrocortisone61$1,092
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine26$884
Neomycin Sulfate32$450
Procto-Med HcHydrocortisone12$362
Metronidazole43$302
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen30$192
Potassium Chloride18$19

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →